Usefulness of heart-type fatty acid-binding protein in patients with severe sepsis

Journal of Critical Care

Volumn 27, Issue 4, 2012, Pages 415.e13-415.e18

  Zhang, Zhao cai ^a,b   Dai, Hai wen ^b   Yu, Yi hua ^b   Yang, Ji dong ^b   Hu, Cai bao ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG HOSPITAL   (China)

Author keywords

Cardiac markers; Heart fatty acid binding protein (hFABP); Myocardial dysfunction; Prognosis; Sepsis

Indexed keywords

ADRENALIN; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; DOBUTAMINE; DOPAMINE; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; MILRINONE; NORADRENALIN; PROCALCITONIN; TROPONIN I; UNCLASSIFIED DRUG; VASOPRESSIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HUMAN CELL; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SEPSIS RELATED MYOCARDIAL DYSFUNCTION; SEPTIC SHOCK; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84864128167     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.01.004     Document Type: Article

References (26)

1. Annane D., Bellissant E., Cavaillon J.M. Septic shock. Lancet 2005, 365:63-78.
2. Charpentier J., Luyt C.E., Fulla Y., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004, 32:660-665.
3. Ver Elst K.M., Spapen H.D., Nguyen D.N., et al. Cardiac troponin I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000, 46:650-657.
4. Lim W., Qushmaq I., Cook D.J., et al. Elevated troponin and myocardial infarction in the intensive care unit: a prospective study. Crit Care 2005, 9:R636-R644.
5. McLean A.S., Huang S.J., Nalos M., et al. The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 2003, 31:2611-2618.
6. Maeder M., Fehr T., Rickli H., et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006, 129:1349-1366.
7. Valle H.A., Riesgo L.G.C., Bel M.S., et al. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome. Eur J Emerg Med 2008, 15:140-144.
8. O'Donoghue M., de Lemos J.A., Morrow D.A., et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006, 114:550-557.
9. Arimoto T., Takeishi Y., Shiga R., et al. Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail 2005, 11:56-60.
10. Puls M., Dellas C., Lankeit M., et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J 2007, 28:224-229.
11. Muehlschlegel J.D., Perry T.E., Liu K.Y., et al. Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery. Anesth Analg 2010, 111:1101-1109.
12. Niizeki T., Takeishi Y., Arimoto T., et al. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. J Card Fail 2007, 13:120-127.
13. Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee.
14. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
15. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
16. Harbarth S., Holeckova K., Froidevaux C., et al. Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402.
17. Caroll J.D., Hess Otto M. Assessment of cardiac function. Braunwald heart disease 2005, 495. McGraw-Hill, New York. 7th ed. D.P. Zipes, P. Libby, E. Braunwald (Eds.).
18. Riedemann N.C., Guo R.F., Ward P.A. The enigma of sepsis. J Clin Invest 2003, 112:460-467.
19. Riedemann N.C., Guo R.F., Ward P.A. Novel strategies for the treatment of sepsis. Nat Med 2003, 9:517-524.
20. Witthaut R., Busch C., Fraunberger P., et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003, 29:1696-1702.
21. Price S., Anning S.B., Mitchell J.A., et al. Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J 1999, 20:715-724.
22. McLean A.S., Huang S.J., Hyams S., et al. Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007, 35:1019-1026.
23. Turner A., Tsamitros M., Bellomo R. Myocardial cell injury in septic shock. Crit Care Med 1999, 27:1775-1780.
24. Ammann P., Fehr T., Minder E.I., et al. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001, 27:965-969.
25. Wu A.H., Feng Y.J., Moore R., et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem 1998, 44:1198-1208.
26. Blanco J., Muriel-Bombin A., Sagredo V., et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008, 12:R158.